Garen Steele, MD
Orthopaedic Surgery · Gulf Breeze, FLNPI 1144423351
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,075 of the $35,901 with a category attached, or 75.4%. Zimmer Biomet accounts for 90.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $11,756 and has fallen 81.8% since, to $2,141 in 2025.
Across 99 payments — averaging $362.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$32K
- Medacta USA, Inc.$2K
- Smith+Nephew$485
- Stryker$309
- Pacira Pharmaceuticals Incorporated$285
- Microport Orthopedics Inc$152
- plus $339 from 5 others
What the payments were for
- Consulting fees$27,07575%
- Travel & lodging$5,09814%
- Food & beverage$3,72810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 61 | $32,472 |
| Medacta USA, Inc. | 14 | $1,860 |
| Smith+Nephew | 8 | $485 |
| Stryker | 2 | $309 |
| Pacira Pharmaceuticals Incorporated | 7 | $285 |
| Microport Orthopedics Inc | 2 | $152 |
| Medical Device Business Services, Inc. | 1 | $139 |
| Johnson & Johnson | 1 | $136 |
| KCI USA, Inc. | 1 | $29 |
| Solventum Corporation | 1 | $20 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PD-Knee-New Product$10,801
- Persona$9,609
- GMK SPHERE$1,561
- PPK$772
- ROSA-Knee$348
- MAKO$309
- ATTUNE$139
- Bioinductive Implant with Arthroscopic Delivery System - Medium$121
- Navio Surgical System$116
- Robotics$103
How this compares
$35,901 in reported general payments places this provider in the 80th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 118 | $907 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $403 |
| Methylprednisolone | 30 | $217 |
| Tramadol Hcl | 63 | $189 |
| Amoxicillin | 68 | $169 |
| Meloxicam | 54 | $166 |
| Ondansetron Hcl | 13 | $137 |
| Cefdinir | 13 | $123 |
| Clindamycin Hcl | 23 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gulf Breeze
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.